Nucleus Genomics
Nucleus Genomics is an American biotechnology company focused on reproductive and preventive genetics.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Nucleus Genomics is an American biotechnology company focused on reproductive and preventive genetics. The company offers genome health testing for adults, genetic analysis of in vitro embryos that includes polygenic risk assessment, and integrated fertility services. The company was founded in 20211 by Kian Sadeghi. Its services have been criticized by a number of geneticists and researchers.
Funding
Nucleus Genomics has raised $32 million across multiple funding rounds. In January 2025, the company raised $14 million in a Series A funding round. Founders Fund, Asylum Ventures, Seven Seven Six, Samsung Next, and One Eight Capital are reported as investors.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374515784 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Nucleus Genomics” date of foundation (×1) · confidence 0.95 revision URL